Qian Zhang

Qian Zhang

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2017 in Trials
Verified
Journal Article
Open access
PDF file
MLMailan Liu
Mailan Liu
QZQian Zhang
Qian Zhang
SJShan Jiang
Shan Jiang
MLMi Liu
Mi Liu
GZGuoshan Zhang
Guoshan Zhang
XCXiaorong Chang
Xiaorong Chang
Acupuncture and moxibustion has been widely applied to hyperlipidemia treatment in clinical practice in China, serving as an alternative treatment to statins. Warm-needling acupuncture and medicinal cake-separated moxibustion have been separately reported with potential therapeutic effects on hyperlipidemia treatment in several studies but with limitations in study methodology. Combining these two modalities may provide a more advantageous strategy in treating hyperlipidemia. Therefore, a strict evaluation through well-designed randomized controlled trials (RCT) is necessary to determine their efficacy and safety on hyperlipidemia. The study a multicenter, open-label, randomized, stratified, active-controlled, noninferiority trial with two parallel groups. Subjects with hyperlipidemia will be stratified into different groups by risk levels of heart diseases. They then will be instructed to the Therapeutic Lifestyle Change (TLC) diet. Those who have not reached the target lipid level will be randomly assigned to the treatments of either acupuncture and moxibustion or simvastatin with a 1:1 allocation. One hundred and thirty subjects are aimed to be recruited. The duration of intervention for this study will be 12 weeks, followed by another 4 weeks for post-treatment assessment. The primary outcome is percentage change from baseline to the end of the study in low-density lipoprotein cholesterol (LDL-C). Other indicators in lipid change, safety and adherence will also be assessed secondarily. The repeated measures, linear mixed-effects model will be applied to the analysis. Acupuncture and moxibustion could be a potentially effective treatment alternative for hyperlipidemia. A study with careful design is developed to evaluate the efficacy and safety of combined acupuncture and moxibustion, by integrating the traditional Chinese Medicine (TCM) regimens with the standardized Western medicine appraisal approach. ClinicalTrials.gov, NCT02269046 . Registered on 26 September 2014.

22 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
UKUthaya Kumaran Kanagaraj
Uthaya Kumaran Kanagaraj
TKTapas Kulkarni
Tapas Kulkarni
EKEddie Kwan
Eddie Kwan
QZQian Zhang
Qian Zhang
JBJeffery Bone
Jeffery Bone
SSSandesh Shivananda
Sandesh Shivananda
Background/Objectives: The numerical risk of bronchopulmonary dysplasia (BPD) and/or death could be estimated using the National Institute of Child Health and Human Development (NICHD) BPD outcome estimator 2022 in extremely low gestational age (ELGA) infants during the first 4 weeks of life to facilitate prognostication, and center-specific targeted improvement interventions. However, the 2022 NICHD BPD outcome estimator’s performance in the Canadian setting has not been validated. Our objective is to validate the NICHD BPD outcome estimator 2022 in predicting death and or moderate to severe BPD at 36 weeks in infants less than 29 weeks admitted to NICU. Methods: A retrospective observational study (March 2022–August 2023) was conducted on both inborn and outborn preterm infants excluding neonates with major congenital anomalies. Infants were classified into six groups based on the predicted risk of death or Grade 2 or 3 BPD ( 0.7 defined a priori as an acceptable predictive accuracy for local use. Results: Among 99 infants included, 13 (13.1%) died, and 40 (40.4%) developed BPD. Median gestational age was 26 weeks, and median birth weight was 914 g. Twenty-three infants (23.2%) received postnatal steroids. The AUC values for death or moderate to severe BPD on days 1, 3, 7, 14, and 28 were 0.803, 0.806, 0.837, 0.832, and 0.843, respectively. The AUC values for moderate to severe BPD alone on those days were 0.766, 0.746, 0.785, 0.807, and 0.818 respectively. Conclusions: The 2022 BPD estimator adequately predicted the death and/or moderate to severe BPD on days 1, 3, 7, 14, and 28 of life. This tool could serve as a valid adjunct to facilitate discussion between clinicians and families on initiating time-sensitive targeted interventions to prevent or alter the course of BPD.

15 May 2023 in Canadian Journal of Diabetes
Verified
Journal Article
Open access
SNSajad Niyyati
Sajad Niyyati
AFAlex Fung
Alex Fung
QZQian Zhang
Qian Zhang
CNCrystal Ng
Crystal Ng
SAShazhan Amed
Shazhan Amed
BHBrenden E. Hursh
Brenden E. Hursh
There was rapid uptake of pediatric diabetes telehealth at the onset of the COVID-19 pandemic and initial studies demonstrated good usability and satisfaction. As exposure to telehealth continued to increase during the pandemic, we aimed to determine changes in telehealth usability and changes in future preferences for telehealth care. A telehealth questionnaire was administered early in the pandemic and again more than one year later. Survey data was linked with a clinical data registry. A multivariable proportional odds logistic mixed effects model was performed to assess the association between exposure to telehealth and outcome of future preference for telehealth. Multivariable linear mixed effects models were used to examine associations between exposure to early and later pandemic periods and the outcome of usability scores. Survey response rate was 40%, with 87 early and 168 later period participants. Virtual visits increased from 46% to 92% of all telehealth visits. Virtual visits improved in ‘ease of use’ (p=0.0013) and ‘satisfaction’ (p=0.045); there were no improvements in telephone visits. The odds of indicating higher preference for more future telehealth visits was 5.1 times higher in the later pandemic group (p=0.0298). 80% of participants would like their future care to include telehealth visits. At our tertiary diabetes centre, families’ desire for future telehealth care has increased during this one-year period of additional telehealth exposure, and virtual care has now become the preferred option. This study provides important family perspectives that can help guide development of future diabetes clinical care.

9 September 2025 in Diabetic Medicine
Verified
Journal Article
Open access
SAShazhan Amed
Shazhan Amed
JBJeffrey N. Bone
Jeffrey N. Bone
SKShreya B. Kishore
Shreya B. Kishore
QZQian Zhang
Qian Zhang
JLJoseph Leung
Joseph Leung
Aims: Our study described incidence and prevalence trends of type 1 diabetes in children and youth under 20 years of age from 1997 to 2023 in the Canadian province of British Columbia (BC) and assessed for a 4‐, 5‐, or 6‐year cyclicity or increase in incidence during the COVID‐19 pandemic. Methods: Using linked population‐level databases and a validated case‐finding and diabetes differentiating algorithm, we identified children with type 1 diabetes diagnosed between 1997 and 2023. Data sources included hospital admissions, outpatient physician visits, and dispensed prescriptions. Population denominators were based on annual age‐ and sex‐stratified population estimates. We calculated incidence per 100,000 and prevalence per 100 cases, using JoinPoint regression to identify trend changes. Cyclical patterns were tested using sine and cosine terms. Results: From 1997 to 2023, the incidence of paediatric type 1 diabetes increased markedly until 2008 and then declined very gradually, with similar patterns across age and sex. Incidence was higher in boys, highest among children aged 5 to 14 years, and lowest in those aged 15 to 19 years. After 2012, prevalent cases stabilized in those under 10 and decreased in those over 10 years old. There was no evidence of cyclical trends or changes in incidence or prevalence during or after the COVID‐19 pandemic. Conclusions/Interpretation: We report a stabilization of type 1 diabetes incidence and prevalence, along with the absence of pandemic‐related increases. These trends may in part reflect demographic changes in British Columbia's paediatric population, including a growing proportion of children from immigrant backgrounds with historically lower type 1 diabetes risk. Unfortunately, our data sources do not include ethnicity, limiting our ability to explore these patterns directly. This study will support the optimization of resource allocation and inform healthcare improvement and long‐term management of childhood type 1 diabetes.

5 January 2023 in Clinical Genetics
Verified
Journal Article
Closed access
PGPeter Grant
Peter Grant
CCCourtney B. Cook
Courtney B. Cook
SLSylvie Langlois
Sylvie Langlois
JNJennifer Nuk
Jennifer Nuk
SMSzeWing Mung
SzeWing Mung
AEAlison M. Elliott
Alison M. Elliott

15 February 2024 in Patient Education and Counseling
Verified
Journal Article
Open access
AFAlex Fung
Alex Fung
DHDori Howard
Dori Howard
HNHeather Nichol
Heather Nichol
MIMichael A. Irvine
Michael A. Irvine
QZQian Zhang
Qian Zhang
BHBrenden E. Hursh
Brenden E. Hursh
To assess the effectiveness of a standardized bi-weekly six-month telephone coaching intervention for parents of children with type 1 diabetes. This single-blind randomized controlled trial followed participants for 12 months. The primary outcome was children's health-related quality of life. Secondary outcomes included treatment adherence, diabetes-related family conflict, and hemoglobin A1c. Data was collected using validated questionnaires and health records. We compared groups using a linear mixed effects model. 102 families were randomized (control: n = 49; intervention: n = 53). Coaching had no impact on children's overall health-related quality of life or overall secondary outcomes; however, there were patterns in subsections that suggest the possible impact of coaching. Coaching was perceived as a positive addition to routine care by 80% of families and 82% would recommend working with a coach to another family. 58% of participants would continue coaching beyond the study. Coaching did not impact overall quality of life or secondary outcomes; however, coaching was well received by families who perceived significant benefits. Patterns in subsections warrant further study. Adding a health coach into diabetes multidisciplinary care supports families in a way that is unique from their routine clinical care.